BIORASIS Inc. aims to commercialize a wireless, miniaturized implantable glucose sensor for long-term diabetes management. The unique aspect of our patented sensor stems from technological innovations in sensor (i) powering, (ii) logic, (iii) wireless communication, (iv) auto-calibration, (v) biocompatible coatings, and (vi) miniaturized size (0.5x0.5x5 mm). The revolutionary size of our sensor is 100 times smaller than our closest competitor and permits implantation through a regular 16-gauge hypodermic needle. An implant of such small size substantially reduces tissue injury, enhances sensor reliability and at the same time increases patient acceptability.
Biorasis’ mission is to provide quality glucose sensors that combine high-accuracy, long-term performance and value pricing in order to meet and exceed our customer’s needs and expectations.
Biorasis Inc
Storrs, CT
Ioannis Tomazos, CEO
http://www.bio-orasis.com
Biorasis, Inc, and their CEO Ioannis Tomazos won the "Most Promising New Life Sciences Company of the Year"as part of the Fifth Annual Innovation Pipeline Awards. Congratulations!
This company has been selected as a 2011 CT Tech Company to Watch, for more information visit,http://www.ct.org/Innovation_Pipeline.asp.
Click here for the year's event recap--> http://bit.ly/tdNqwc
Comments